retatrutide clinical trial results obesity Shows 28% Weight Loss in 80 Weeks Retatrutide trial results in 28

Mayo Clin

The Journal of Neuroscience, 23, 29392946

The following a balanced eating plan and reducing calorie intake getting regular physical activity setting weight goals asking for support from family, friends, and healthcare professionals enrolling in a weight loss program If a person wishes to lose a large amount of weight, they should consult a healthcare professional first

Conditions like Crohn disease, ulcerative colitis, and celiac disease all involve compromised gut barrier function

In a Phase 2 obesity trial of retatrutide published in the New England Journal of Medicine in 2023, nausea, diarrhea, vomiting and constipation were cited as the most common adverse events, with higher doses associated with more severe problems

Do GLP-1 patches work as well as injections